Wilson Therapeutics AB

March 10, 2021

Wilson developed a novel therapeutic for Wilson Disease, a rare genetic disease characterized by excess copper storage. Alexion Pharmaceuticals acquired Wilson Therapeutics in 2018 for $855 million.

Latest news

Quell Therapeutics Expands Manufacturing Capabilities Through Partnership with eXmoor Pharma

September 24, 2024

Stryker agrees to acquire Vertos Medical

August 22, 2024

eXmoor Pharma’s GMP cell and gene therapy manufacturing facility receives license from MHRA

August 20, 2024

Providence Medical Technology, Inc. Announces FDA Clearance of CORUS™ Navigation Access System for Use with Medtronic’s StealthStation™ Surgical Navigation in Posterior Spinal Fusion

June 13, 2024

Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study

June 4, 2024

GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.

April 15, 2024

Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps

March 15, 2024

GT Medical Technologies Names Per Langoe As CEO

February 20, 2024

MVM invests in icotec

January 24, 2024

MVM invests in Gynesonics

November 1, 2023

View all

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others